Use LEFT and RIGHT arrow keys to navigate between flashcards;
Use UP and DOWN arrow keys to flip the card;
H to show hint;
A reads text to speech;
87 Cards in this Set
- Front
- Back
on average, what is the amount of our total body water?
|
42L
|
|
on average, what is the amount of our extracellular fluid (ECV)?
|
14L
|
|
on average, what is the amount of our intracellular fluid?
|
28L
|
|
two compartments within the extracellular?
|
1. Interstitial fluid (11L)
2. Plasma (3L) |
|
ratio of TBW: ICV: ECV
|
60:40:20
|
|
what would alter the percentage of our body weight that is water?
|
fat content (increase fat, decrease water)
|
|
which compartment do RBCs fall into?
|
intracellular
|
|
which electrolyte is found in highest concentration in the intracellular compartment?
|
K+
|
|
which electrolytes are found in highest concentration in the extracellular compartment? (3)
|
Na+
Cl- HCO3- |
|
if you hydrate a patient with IV saline, in which compartment does the fluid distribute?
|
extracellular
|
|
what are some clinical s/s that indicate an expanded ECF volume? (5)
|
1. HTN
2. elevated JVP 3. hepatic congestion 4. hepatojugular reflex 5. edema, rales |
|
what are some clinical s/s that indicate a diminished ECF volume? (7)
|
1. orthostatic hypotension
2. decreased JVP 3. hypotension 4. shock 5. dry mouth and membranes 6. diminished skin turgor 7. diminished intraocular pressure |
|
3 lab values that would indicate a diminished ECFV?
|
1. BUN/Cr > 20
2. FENA <1% 3. Urine osmolality >600mOSM/L |
|
what is the formula for calculating FENA?
|
FENA = U[Na+] / P[Na+] x P[Cr] / U[Cr] x 100
|
|
treatment for an ECFV loss?
|
infuse isotonic saline (4:1)
|
|
what is the site of action of thiazide diuretics?
|
distal tubule
|
|
which ion do thiazides excrete in urine?
|
NaCl
K+ |
|
which type of diuretic is used to treat glaucoma?
|
carbonic anhydrase inhibitor
(acetazolamide) |
|
site of action of carbonic anhydrase inhibitors?
|
proximal tubule
|
|
ions excreted in urine when using a carbonic anhydrase inhibitor?
|
NaHCO3
(great for use in volume overload or alkalotic patient - gets rid of bicarb) |
|
where do K+ sparing diuretics work?
|
distal and cortical collecting tubule
|
|
name three K+ sparing diuretics
|
1. triamterene
2. amiloride 3. spironolactone |
|
site of action of loop diuretics?
|
Loop of Henle - Duh!
:) |
|
MOA of loop diuretics?
|
inhibit Na/K/Cl pumps, therefore ions aren't pumped out of the lumen
|
|
what could make a loop diuretic not work?
|
they must be secreted into the proximal tubule, so if there is no secretion they won't work.
|
|
where in the nephron are Na+ channels found on the apical membrane?
|
in the DT and CD
|
|
where in the nephron is NaCl symport found?
|
DT
|
|
on which side of the tubular epithelial cell is the Na/K/ATPase found?
|
basolateral membrane (interstitial side)
|
|
which hormone regulates Na+ transport in the distal tubule and collecting duct?
|
Aldosterone
|
|
what effect does increased fluid flow in the tubular lumen have on K+ excretion?
|
increase flow -> increase K+ excretion
(diffusion only, remember?) |
|
if you can't concentrate your urine, what three types of problems could you have?
|
1. Loop Problem
2. No ADH production or release 3. No receptors for ADH in CD |
|
how does ADH regulate urine concentration?
|
adds water channels (aquaporins) to the collecting duct: water diffuses out as needed
|
|
if ADH regulates water retention, what does Aldosterone regulate?
|
Na+ retention
|
|
what are the two receptors for ADH?
|
V1 - vascular smooth muscle
V2 - distal tubule and collecting duct |
|
which receptors can trigger ADH release?
|
1. osmoreceptors in hypothalamus (sense plasma osmolality and [Na+])
2. low volume receptors (atria) 3. arterial baroreceptors |
|
which receptor is the most sensitive?
|
osmoreceptors
|
|
what happens to [Na+] during ECFV depletion?
|
hyponatremia
|
|
at what plasma [Na+] do we start to have serious neurological concerns?
|
Plasma [Na+] <120 mMol/L
|
|
what is the formula to calculate plasma osmolarity?
|
Posm = 2 x [PNa+] + [glucose] / 18 + BUN/2.8
|
|
what [PNa+] counts as hyponatremia?
|
[PNa+] < 130 mEq/L
|
|
using the Posm formula: how would we know if we had pseudohyponatremia?
|
if the measured Posm >10 mOsm greater than calculated Posm. (This means there is an extra osmolyte producing hyponatremia via osmoreceptor stimulated ADH release)
|
|
what is the most common euvolemic cause of hyponatremia?
|
SIADH (syndrome of innapropriate ADH secretion)
|
|
what is the therapy for hypovolemic hyponatremia?
|
isotonic saline infusion
|
|
what is the therapy for euvolemic hyponatremia?
|
fluid restriction
|
|
therapy for hypervolemic hyponatremia?
|
fluid restriction
|
|
clinically, which is more dangerous: hypernatremia or hyponatremia?
|
hyponatremia
|
|
what [PNa+] couts as hypernatremia?
|
[PNa+] > 145 mEq/L
|
|
in a hypernatremic state which fluid compartment is depleted?
|
intracellular fluid compartment
|
|
what are the three main classes of causes of hypernatremia?
|
1. pure water loss
2. more water loss than Na+ loss 3. Sodium gain in excess of water |
|
examples of pure water loss resulting in hypernatremia?
|
1. respiratory
2. burns 3. DI (ADH deficiency) 4. nephrogenic DI (no AHD receptors) |
|
two ways there could be more water loss than Na+ loss?
|
1. GI losses
2. Diuretics |
|
therapy for hypernatremia?
|
add water
remove salt from diet |
|
what are some ways to differentiate DI (nephrogenic or central)?
|
1. measure AHD blood levels
(increased in nephrogenic DI, decreased in central DI) 2. water deprivation test (complete DI will respond to exogenous ADH, NDI will not) |
|
what is the MC outpatient cause of acute renal failure?
|
NSAIDs
|
|
clinical recognition of drug-induced renal disease?
|
1. increased BUN, SCr
2. decreased urine output |
|
what symptoms are associated with uremia?
|
malaise
anorexia vomiting |
|
clinically, how can you tell if the proximal tubule vs. the distal tubule is damaged?
|
proximal tubule: glycosuria, hypophosphatemia, hypouricemia
distal tubule: polyuria, hyperkalemia |
|
which drug classes are MC associated with drug-induced renal disease? (6)
|
1. aminoglycosides
2. amphotericin B 3. NSAIDs 4. ACEIs and ARBs 5. Radiocontrast dyes 6. chemotherapeutic agents (cisplatin) |
|
what is pseudo-renal failure?
|
a rise in BUN and/or SCr despite a normal GFR
|
|
what could cause pseudo-renal failure? (3)
|
1. steroids
2. tetracyclines 3. patients of TPN (due to high aa content) |
|
what is the pathogenesis behind renal damage caused by ACEIs and ARBs?
|
decreased glomerular capillary hydrostatic pressure
(pressure at glomerulus is reduced, therefore GFR is reduced) |
|
which 2 vasoactive substances act on the afferent arteriole?
|
1. PGE2
2. angiotensin II |
|
which vasoactive substance acts on the efferent arteriole?
|
angiotensin II
|
|
what are two risk factors for renal disease caused by ACEIs/ARBs?
|
1. Renal Artery Stenosis
2. decresed effective arterial renal blood flow for any reason |
|
how can renal disease caused by ACEIs/ARBs be prevented?
|
when starting the medication:
use a short acting med (captopril), start with low doses, and titrate slowly. if all is well convert to long term med. *monitor renal function and K+ during initiation of therapy* |
|
how can we manage acute hyperkalemia if it is seen with renal disease caused by ACEIs/ARBs?
|
sodium polystyrene sulfate (kaexalate - K+ binding agent).
|
|
which NSAID has been associated with ARF after just one dose?
|
ketorolac
(parenteral NSAID) |
|
pathogenesis of ARF caused by NSAIDs?
|
* COX inhibitor decreases prostaglandin synthesis
* no more vasodilatory prostaglandins to dilate afferent arteriole. get unopposed vasoconstriction -> reduced blood flow -> decreased GFR |
|
other analgesics that have less prostaglandin inhibition (therefore we would recommend them for anyone at risk for ARF)? (3)
|
acetaminophen
sulindac nonacetylated salicylates |
|
what is unique about the clinical presentation of ARF caused by aminoglycosides?
|
decreased urine volume is uncommon.
(ARF caused by other drugs typically presents with decreased urine output). |
|
pathogenesis of aminoglycoside induced nephrotoxicity? (big picture)
|
* proximal tubul epithelial cell damage leads to obstruction of tubular lumen and backleak of glomerular filtrate across damaged epithelium.
|
|
how does nephrotoxicity vary among different aminoglycosides?
|
nephrotoxicity is related to the # of cationic charges the drug has (facilitates binding to epithelial cell)
* neomycin has highest nephrotoxicity (most + groups) * gentamycin - intermediate * amikacin - least |
|
what happens once the aminoglycosides are bound to the epithelial cell?
|
they are taken up into the cells and concentrated in the lysosomes
*cellular dysfunction and death is due to release of lysosomal enzymes |
|
risk factors (related to dosing)that lead to aminoglycoside nephrotoxicity? (4)
|
1. large total accumulated dose
2. prolonged therapy 3. high trough concentrations 4. recent previous aminoglycoside therapy |
|
four drugs that synergistically can be nephrotoxic alongside aminoglycosides?
|
1. cyclosporine
2. amphotericin B 3. vancomycin 4. diuretics |
|
prevention of aminoglycoside toxicity?
|
* adequate hydration
* avoid concomitant nephrotoxic drugs * higher doses less frequently (once daily) |
|
what is an alternative antibiotic that is "kidney friendly" if a switch from aminoglycosides is desired?
|
Ciprofloxacin
|
|
when a patient is on aminoglycosides - how often should SCr be monitored?
|
every 2-4 days
|
|
what is the pathogenesis of radiographic contrast media induced nephrotoxicity?
|
direct tubular toxicity and renal ischemia
-ischemia is due to dehydration (contrast dye is a very osmolar compound, acts as a diuretic) |
|
#1 prevention tactic for radiographic contrast media nephrotoxicity?
|
HYDRATION
(isotonic saline IV) |
|
what is mucormyst (n-acetylcysteine)?
|
antioxidant, free radical scavenger - thought to lower chances of radiographic contrast media induced nephrotoxicity?
|
|
what is the pathogenesis of cisplatin induced nephrotoxicity?
|
proximal, distal and collecting duct tubular necrosis
|
|
4 risk factors for cisplatin induced nephrotoxicity?
|
1. increased age
2. dehydration 3. renal irradiation 4. ETOH abuse |
|
what can be administered if a patient has cisplatin induced nephrotoxicity?
|
amifostine
(Chelates cisplatin) |
|
pathogenesis of Amphotericin B induced nephrotoxicity?
|
proximal and distal tubule damage
(direct toxicity with increased tubular permeability and necrosis) - results in arterial vasoconstriction |
|
Cockraft-Gault formula for estimating creatinine clearance (CrCl)?
|
CrCl = (140-age)LBW / 72(SCr)
|
|
what is the CrCl "cutoff" for renal dosing?
|
when CrCl is below 30 - dose adjustment required
|